Received Jun 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
developed high blood pressure; dizziness; shortness of breath; persistent tiredness; who has since passed away; lung cancer; This is a spontaneous report received from a Consumer or other non HCP. A 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). Concomitant medication(s) included: AZATHIOPRINE. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for Covid-19 immunization. The following information was reported: LUNG NEOPLASM MALIGNANT (disability, life threatening) with onset 2023, 9 months after the suspect product(s) administration, outcome "not recovered", described as "lung cancer"; DEATH (death), outcome "fatal", described as "who has since passed away"; HYPERTENSION (disability, life threatening), outcome "not recovered", described as "developed high blood pressure"; DIZZINESS (disability, life threatening), outcome "not recovered"; DYSPNOEA (disability, life threatening), outcome "not recovered", described as "shortness of breath"; FATIGUE (disability, life threatening), outcome "not recovered", described as "persistent tiredness". Clinical course: The patient had passed away. Soon after taking the Covid vaccine booster (Pfizer), she developed high blood pressure that had never been seen in her lifetime. She experienced dizziness and shortness of breath. This led to reduced activity level and persistent tiredness. 9 months after the vaccine, she was detected with lung cancer even though all her previous assessments were clean. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: high. Therapeutic measures were not taken as a result of death, lung neoplasm malignant, hypertension, dizziness, dyspnoea, fatigue. The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 will be requested and submitted if and when received.; Reported Cause(s) of Death: who has since passed away
Medical History/Concurrent Conditions: Rheumatoid arthritis
AZATHIOPRINE
Test Name: blood pressure; Result Unstructured Data: Test Result:high